POCI
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
Precision Optics Corporation, Inc. (POCI) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (B); its weakest is Value (D+). The rating has held at C+ for 7 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-14 | D+ (1.5) | B (3.5) | B- (3.0) | B- (3.1) | C+ (2.6) | C+ (2.8) |
| 2026-11-07 | D+ (1.5) | B (3.5) | B- (3.0) | B (3.3) | C+ (2.7) | C+ (2.8) |
| 2026-10-31 | D+ (1.5) | B (3.5) | B- (3.0) | B- (3.0) | C+ (2.7) | C+ (2.8) |
| 2026-10-24 | D+ (1.6) | B (3.5) | B- (3.0) | B- (3.0) | C+ (2.6) | C+ (2.7) |
| 2026-10-17 | D+ (1.6) | B (3.5) | B- (3.0) | C+ (2.7) | C+ (2.6) | C+ (2.7) |